SXR8 ETF Review — iShares Core S&P 500 (Xetra) for Polish Investors 2026

Quick Answer

SXR8 is the Xetra ticker for iShares Core S&P 500 UCITS ETF (Acc) — the same Irish-domiciled fund as CSPX (London ticker), IUSA (distributing variant uses different ticker), and several other regional listings. Key facts:

• ISIN: IE00B5BMR087
• TER: 0.07% per year (one of the cheapest S&P 500 UCITS funds)
• AUM: ~€90B+ (largest UCITS S&P 500 ETF by assets)
• Distribution: Accumulating (dividends auto-reinvested, no payout)
• Domicile: Ireland (UCITS) — tax-efficient for EU investors
• Trading currency on Xetra: EUR
• Where to buy in Poland: XTB, mBank eMakler, Bossa, Trading 212, Revolut, Interactive Brokers, Degiro

If you want a single low-cost vehicle for US large-cap exposure and you trade primarily on Xetra (or your broker only supports Xetra for iShares Core S&P 500), SXR8 is the ticker you're looking for. The underlying fund is identical to CSPX — same NAV, same holdings, same TER, same dividend treatment. Only the listing exchange and trading currency differ.

This review covers what SXR8 is (and what it is not), why the ticker confuses people, where Polish investors can buy it, IKE/IKZE eligibility, tax treatment under Polish law, and how it compares against alternatives such as VUAA (Vanguard S&P 500 UCITS) and US-domiciled VOO.

What SXR8 actually is — clearing up the confusion

The "SXR" prefix on Deutsche Börse Xetra is shared by several iShares Core ETFs. The most-searched one is SXR8 = iShares Core S&P 500 UCITS ETF (Acc), ISIN IE00B5BMR087. People sometimes confuse this with S&P Europe 350 or other indices because of the "SXR" prefix — but SXR8 specifically tracks the S&P 500 (US large caps), not a European index.

The same fund (same ISIN) lists under different tickers on different exchanges:

• CSPX — London Stock Exchange (USD)
• CSPX.L — same as above, with explicit exchange suffix used by some brokers
• SXR8 — Deutsche Börse Xetra (EUR)
• CSSPX — Borsa Italiana (EUR)
• CSPX.SW — SIX Swiss Exchange (CHF)

All five tickers point to the same underlying fund: iShares Core S&P 500 UCITS ETF (Acc), Irish-domiciled, IE00B5BMR087. NAV is calculated once per day by BlackRock — it does not differ by exchange. What differs is the trading currency, the bid-ask spread, and the broker commission you pay to access that exchange.

Note: IUSA (ISIN IE0031442068) is the distributing version — same index, but pays out dividends quarterly. SXR8 does not pay dividends; they are reinvested inside the fund automatically.

Index methodology

SXR8 tracks the S&P 500 Total Return (Net) Index in EUR terms (the index itself is calculated in USD; the fund holds USD-denominated stocks). The S&P 500 includes:

• ~500 of the largest US-listed companies by market capitalization
• Sectors weighted by market cap — historically tech-heavy (~30% in 2026 due to NVIDIA, Microsoft, Apple, Meta, Alphabet weights)
• Selection committee (S&P Dow Jones Indices) reviews quarterly — not pure rules-based
• Free-float adjusted weights

Replication is physical, full — BlackRock holds essentially all 500 constituents in proportion to the index. No swap or synthetic exposure. Tracking difference is typically -0.05% to -0.10% per year (slightly worse than the index because of TER and small frictions, slightly better in some years thanks to securities lending revenue).

Accumulating means: dividends paid by the underlying companies (~1.3-1.5% gross yield in 2026) are not paid out to you. They are reinvested by the fund into the index basket. The fund's NAV reflects this — you own a slightly larger claim on the same basket each quarter.

Where to buy SXR8 in Poland

Polish brokers' Xetra access varies. Here is the realistic 2026 landscape:

• XTB — full Xetra access, SXR8 available, 0% commission up to monthly turnover threshold (~100k EUR), then 0.2% with 10 EUR minimum. EUR currency conversion ~0.5% spread. Available in IKE (XTB Emerytalne) account.

• mBank eMakler — Xetra supported, SXR8 available. Commission ~0.29% min ~19 PLN. EUR conversion via mBank's currency service. Available in IKE / IKZE wrapper.

• Bossa (DM BOŚ) — Xetra access via Bossa World, SXR8 in offer. Commission 0.29% min 19 PLN per trade. IKE / IKZE available.

• PKO eMakler / Pekao Bank Polska — Xetra coverage limited; check current offer before assuming SXR8 is on the list. CSPX from London is more often available than SXR8 from Xetra at PL bank brokerages.

• Revolut — offers a curated ETF list including iShares Core S&P 500. The actual ticker exposed to retail users may differ (Revolut typically routes to one venue under the hood); for direct SXR8 on Xetra, a dedicated broker is more reliable. https://revolut.com/referral/?referral-code=rafa9jcta!MAR1-26-AR for a Revolut account.

• Trading 212 — fractional shares of S&P 500 ETFs available, typically routes to one of the listings. Free commission, FX spread applies.

• Interactive Brokers (IBKR) — full Xetra access, SXR8 available, Tier pricing (typically <2 EUR per trade for retail). Best for larger portfolios.

• Degiro — Xetra in their "Free ETF" list historically; check current core selection. SXR8 usually qualifies.

Currency consideration: SXR8 trades in EUR on Xetra, but the underlying companies are USD-denominated. So you have two currency layers: PLN→EUR conversion to fund the trade, and embedded EUR↔USD exposure inside the fund. The fund itself is not currency-hedged — your returns track S&P 500 in USD plus or minus EUR/USD movement, then converted to PLN when you eventually sell.

SXR8 in IKE and IKZE

Yes — SXR8 is eligible for both Polish tax-advantaged accounts wherever the broker supports Xetra inside the IKE/IKZE wrapper:

• IKE limit 2026: 26 019 zł — gains free from Belka tax (19%) when withdrawn after age 60 (and after 5 calendar years of contributions)
• IKZE limit 2026: 10 407 zł (standard) / 15 611 zł (B2B / self-employed) — contributions deductible from current-year tax base, 10% flat tax on withdrawal after age 65

For long-horizon S&P 500 exposure, holding SXR8 inside IKE is mathematically attractive because you skip Belka entirely on decades of compound returns. The accumulating structure pairs well with IKE/IKZE — there are no dividend events to track or report.

Note: check broker-specific availability. XTB Emerytalne, Bossa, and mBank eMakler all support SXR8 inside the wrapper as of early 2026. PKO eMakler's IKE coverage of Xetra ETFs has been narrower historically.

SXR8 vs CSPX vs CSPX.L vs IUSA — what's the difference?

This is the most common SXR8 question. Short answer:

• SXR8 and CSPX are the same fund, different listings. ISIN IE00B5BMR087 in both cases. Choose based on what your broker supports and which trading currency you prefer.
• CSPX.L is a broker-specific notation for CSPX on London — same as CSPX.
• IUSA is the distributing sibling — same index, different ISIN (IE0031442068), pays dividends quarterly.

Picking between SXR8 (Xetra/EUR) and CSPX (LSE/USD) usually comes down to:

• Commission structure — some PL brokers price LSE differently from Xetra. XTB historically had similar pricing for both.
• FX path — if your broker auto-converts PLN→EUR for free or cheaply, SXR8 is convenient. If it auto-converts to USD, CSPX may be smoother.
• Spread — both venues are highly liquid; spread differences are small (~0.02-0.05%) for retail-size trades.
• Time zone — Xetra opens 9:00 CET, LSE 9:00 BST (10:00 CET) — practically simultaneous.

For Polish investors with PLN-funded accounts, neither has a structural advantage. Pick whichever your primary broker handles more cheaply.

SXR8 vs VUAA (Vanguard S&P 500 UCITS Acc)

Both are Irish-domiciled, accumulating, S&P 500 trackers. Differences:

• TER: SXR8 0.07% vs VUAA 0.07% — identical as of 2026 (Vanguard cut from 0.07% in past years to match)
• AUM: SXR8 ~€90B+ vs VUAA ~€20B+ — SXR8 dominates
• Replication: both physical, full
• Tracking difference: historically very close, both within -0.05% to -0.10%
• Issuer: BlackRock (iShares) vs Vanguard — preference often comes down to brand loyalty, not measurable performance
• Liquidity: SXR8 has tighter spreads on Xetra; VUAA has slightly wider but still negligible for retail

Either is a defensible choice for S&P 500 exposure. Some investors hold both to diversify provider risk.

SXR8 vs VOO (US-domiciled Vanguard S&P 500 ETF)

VOO is the US-listed S&P 500 ETF — TER 0.03%, ~$500B AUM. Cheaper on paper, but:

• PRIIPs/MiFID II restrictions: EU retail investors cannot easily buy VOO since 2018 because Vanguard does not provide a KID (Key Information Document). Most EU retail brokers block US-domiciled ETFs entirely.
• Withholding tax: US ETFs deduct 30% withholding on dividends without W-8BEN, 15% with treaty (Polish residents qualify). On a 1.4% dividend yield, that's ~21 bps drag — wiping out the TER advantage vs SXR8.
• Estate tax exposure: US-domiciled assets above $60k can trigger US estate tax for non-resident aliens. Irish UCITS bypasses this entirely.

For Polish residents using EU brokers, Irish UCITS like SXR8 are the practical route to S&P 500 exposure. VOO is mostly inaccessible.

Tax treatment for Polish investors

Outside IKE/IKZE wrappers:

• Capital gains on sale: 19% Belka tax (PIT-38), reported by the investor each April for prior year. Brokers issue PIT-8C (mostly PL brokers — foreign brokers like IBKR do not, you self-calculate from statements).
• Dividends: SXR8 is accumulating, so there is no dividend event for you to report. The fund itself receives dividends inside, US withholding (~15% under US-Ireland treaty) is deducted at the fund level. You see the net result in the NAV.
• No double tax: because there is no payout, you don't get hit with PL Belka on dividends as well — only on the eventual capital gain when you sell.
• W-8BEN: not needed. The Irish UCITS structure handles US withholding via the US-Ireland tax treaty — no paperwork on your side.

This tax efficiency is the structural reason most Polish investors hold the Irish UCITS (SXR8/CSPX) rather than US-listed (VOO/SPY). Even if VOO had 0% TER, the dividend tax friction would erase the advantage at the typical 1.3-1.5% yield.

Inside IKE: zero tax on the gain when withdrawn after age 60 with 5 years of contributions. Inside IKZE: 10% flat tax on the entire withdrawal (capital + gains) after age 65.

Costs — the full picture

Headline TER 0.07% is one number. Real cost includes:

• TER 0.07% — paid daily, embedded in NAV
• Tracking difference — typically -0.05% to -0.10% — fund slightly underperforms index
• Bid-ask spread on Xetra — ~0.02-0.05% per round trip for retail size
• Broker commission — varies; XTB 0% under threshold, mBank/Bossa ~0.29% min ~19 PLN
• FX conversion — PLN→EUR at your broker's spread, typically 0.3-0.7%
• PL Belka 19% on capital gains outside IKE/IKZE

For a buy-and-hold investor with a 10+ year horizon, the FX conversion (paid once at purchase) and TER dominate. Trading frequently amplifies spread and commission costs.

Risks to know

• Concentration in US large-caps — SXR8 is essentially a bet on the US economy and US-listed multinationals. Top 10 holdings (NVIDIA, Microsoft, Apple, Amazon, Meta, Alphabet x2 share classes, Berkshire, JPMorgan, ExxonMobil) make up ~33% of the fund as of 2026.
• Tech concentration — ~30% in technology sector. A repeat of 2000-2002 dot-com correction would hit hard.
• No currency hedge — PLN-denominated investor takes on EUR/USD/PLN exposure. In a PLN-strengthening environment, USD returns get diluted.
• Single-country risk — no exposure to Europe, Japan, emerging markets, China. Many investors pair SXR8 with a global ETF (VWCE, ISAC) or specifically EM (EIMI) for diversification.
• No active management — when the index drops 30%, your fund drops ~30% too. There is no defensive rotation.

These are inherent to passive S&P 500 exposure, not specific to SXR8. They apply equally to CSPX, VUAA, and any other S&P 500 tracker.

Excel vs portfolio tracker

Many SXR8 holders track positions in Excel: ticker, units, average cost, current value pulled from a manual Yahoo Finance lookup. That works for one ETF. The moment you add EIMI for emerging markets, an EUNA bond ETF, plus IKE and IKZE wrappers in different brokers, the spreadsheet becomes a maintenance burden. Each rebalance requires re-pulling prices, recomputing FX, and adjusting cost basis.

Freenance integrates with XTB, Bossa, and other Polish brokers — your SXR8 position updates automatically along with everything else in your portfolio. No manual price refresh, no FX recomputation. The Belka tax estimator tracks unrealized gains in PLN so you know what you'd owe if you sold today.

FAQ

Is SXR8 the same fund as CSPX?

Yes. Both tickers point to iShares Core S&P 500 UCITS ETF (Acc), ISIN IE00B5BMR087. SXR8 is the Xetra (EUR) listing, CSPX is the London (USD) listing. NAV is identical, holdings are identical, TER is identical (0.07%).

Can I buy SXR8 on PKO eMakler?

PKO eMakler's foreign exchange coverage is narrower than XTB or Bossa. Check current offer in your account dashboard. CSPX from London is more often available than SXR8 from Xetra at PL bank brokerages. If SXR8 is not listed, CSPX gives you the same underlying fund.

Is SXR8 eligible for IKE?

Yes, on brokers that support both Xetra and the IKE wrapper. XTB Emerytalne, Bossa IKE, and mBank eMakler IKE all support SXR8 as of 2026.

What is the dividend policy of SXR8?

Accumulating — dividends paid by underlying companies (~1.3-1.5% gross yield in 2026) are reinvested inside the fund. You receive no cash distributions. The fund's NAV reflects the reinvestment.

Why is SXR8 sometimes labeled "S&P Europe 350"?

It is not. SXR8 tracks the S&P 500 (US large caps), not S&P Europe 350. The "SXR" prefix is shared across multiple iShares Core ETFs on Xetra, which causes confusion. Always verify by ISIN: IE00B5BMR087 = iShares Core S&P 500.

SXR8 vs VUAA — which is better?

Both have 0.07% TER, both Irish-domiciled, both accumulating, both physical replication. SXR8 has larger AUM and slightly tighter spreads on Xetra. VUAA might be marginally easier to access on some non-DE brokers. There is no measurable performance difference — pick based on broker support and brand preference.

How does Polish Belka tax apply to SXR8 outside IKE?

On sale, your capital gain (sell price minus average buy cost, both in PLN) is taxed at 19%. Reported on PIT-38 by April 30 of the following year. PL brokers issue PIT-8C; foreign brokers (IBKR, Degiro) require self-calculation from CSV statements.

Do I need to file W-8BEN for SXR8?

No. The Irish UCITS structure handles US withholding tax internally via the US-Ireland treaty. There is no W-8BEN paperwork on your side as a Polish investor.

Is SXR8 currency-hedged?

No. SXR8 holds USD-denominated stocks, trades in EUR, and your gain in PLN reflects the full chain of FX movement. There is no currency hedge built into the fund.

Can I DCA into SXR8?

Yes, this is the most common usage pattern. Some brokers (XTB, mBank eMakler) support automated monthly purchases of fractional or full shares. Manual monthly orders also work. DCA helps smooth out USD/EUR/PLN volatility over time.

What is the minimum purchase for SXR8?

On Xetra, minimum is one share — currently around 600+ EUR. On Trading 212 or Revolut you can typically buy fractional units starting from 1 EUR. On XTB and mBank eMakler, full shares only — so several hundred EUR minimum per trade.

Does SXR8 lend out securities?

Yes, BlackRock engages in securities lending on iShares Core ETFs. Revenue from lending offsets a small portion of TER and tracking difference. Disclosed in the annual report. Lending is collateralized.

Where can I check SXR8's current holdings?

ishares.com → search SXR8 or IE00B5BMR087 → "Holdings" tab. Updated daily. The full constituent list mirrors the S&P 500 — ~500 stocks plus a small cash buffer.

What happens if BlackRock liquidates SXR8?

Extremely unlikely given €90B+ AUM. If it ever happened, holders would receive the NAV in cash on the liquidation date. No loss of principal beyond market movement.

Is SXR8 a good single-ETF portfolio for a Polish investor?

For pure US large-cap exposure, yes. For diversification across regions, many investors pair SXR8 with a global ETF (VWCE, ISAC) or with EM (EIMI) and developed-markets-ex-US (EUNL). Single-country concentration is a real risk to acknowledge.

This article is informational and does not constitute investment advice. Past performance does not guarantee future returns. Consider consulting a licensed advisor before making investment decisions.